Issuer · CIK 0002007191

TLX — Telix Pharmaceuticals Ltd

Recent filings

May 7, 2026·Form 4·Pro · in 21h 56m$•••K
TLX/Telix Pharmaceuticals Ltd
Behrenbruch Christian · MD & Group CEO
Proonly

← Back to all filings

TLX (Telix Pharmaceuticals Ltd) — recent insider filings — Form 4 AI